MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617078574 A) filed by Aphaia Pharma AG on June 25, 2026, for Treatment Of Obesity And Related Conditions By Circadian Administration Of Enterokine- Stimulating Compositions.
Inventor includes Bolz, Steffen-Sebastian.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention relates to the treatment and prevention of obesity and/or conditions associated therewith in a subject, preferably a human, in need thereof by at least twice daily circadian oral administration of at least two doses of the composition. The invention further relates to the corresponding use of the composition for the treatment and/or prevention of obesity and/or conditions associated therewith.
Disclaimer: Curated by HT Syndication.
